Chemiluminescence immunoassay for vascular endothelial growth factor (vascular permeability factor) in tumor-tissue homogenates

Clinical Chemistry

Volumn 42, Issue 11, 1996, Pages 1777-1784

  Schlaeppi, Jean Marc ^a   Eppenberger, Urs ^b   Martiny Baron, Georg ^c   Küng, Willy ^b  

^a CIBA GEIGY LTD   (Switzerland)

^b UNIVERSITY WOMEN S HOSPITAL   (Switzerland)

^c TUMOR BIOLOGY CENTER   (Germany)

Author keywords

angiogenesis; breast cancer; monoclonal antibody; ovarian cancer; polyclonal antibody

Indexed keywords

MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; BREAST CARCINOMA; CHEMOLUMINESCENCE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVARY CARCINOMA; PATIENT SELECTION; PROGNOSIS; PROTEIN DETERMINATION;

EID: 0029801959     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/42.11.1777     Document Type: Article

References (35)

1. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990;82:4-6.
2. Folkman J. The role of angiogenesis in tumor growth. Semin Cancer Biol 1992;3:66-71.
3. Weidner N. Tumor angiogenesis: review of current applications in tumor prognostication. Semin Diagn Pathol 1993;10:302-13.
4. Folkman J, Shing Y. Angiogenesis. J Biol Chem 1992;267: 10931-4.
5. Senger DR, Van De Water L, Brown LF, Nagy JA, Yeo KT, Yeo TK, et al. Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev 1993;12:303-24.
6. Senger DR, Brown LF, Claffey KP, Dvorak HF. Vascular permeability factor, tumor angiogenesis and stroma generation. Invasion Metastasis 1994-95;14:385-94.
7. Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995;146:1029-39.
8. Maglione D, Guerriero V, Viglietto G, Delli-Bovi P, Persico MG. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci U S A 1991;88:9267-71.
9. Tischer E, Mitchell R, Hartman T, Silva M, Gospodarowicz D, Fiddes JC, Abraham JA. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 1991;266:11947-54.
10. Houck KA, Ferrara N, Winer J, Cachianes G, Li B, Leung DW. The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 1991;5:1806-14.
11. Keck PJ, Hauser SC, Krivi G, Sanzo K, Warren T, Feder J, Connolly DT. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 1989;246:1309-12.
12. Houck KA, Leung DW, Rowland AM, Winer J, Ferrara N. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem 1992;267: 26031-7.
13. De Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 1992;255:989-91.
14. Terman BI, Dougher-Vermazen M, Carrion ME, Dimitrov D, Armellino DC, Gospodarowicz D, Böhlen P. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem Biophys Res Commun 1992;187:1579-86.
15. Kolch W, Martiny-Baron G, Kieser A, Marmé D. Regulation of the expression of the VEGF/VPS and its receptors: role in tumor angiogenesis. Breast Cancer Res Treat 1995;36:139-55.
16. Ferrara N. The role of vascular endothelial growth factor in pathological angiogenesis. Breast Cancer Res Treat 1995;36: 127-37.
17. Brown LF, Berse B, Jackman RW, Tognazzi K, Guidi AJ, Dvorak HF, et al. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptor in breast cancer. Hum Pathol 1995;26:86-91.
18. Olson TA, Mohanraj D, Carson LF, Ramakrishnan S. Vascular permeability factor gene expression in normal and neoplastic human ovaries. Cancer Res 1994;54:276-80.
19. Boocock CA, Charnock-Jones DS, Sharkey AM, McLaren J, Barker PJ, Wright KA, et al. Expression of vascular endothelial growth factor and its receptors fit and KDR in ovarian carcinoma. J Natl Cancer Inst 1995;87:506-16.
20. Toi M, Hoshina S, Takayanagi T, Tominaga T. Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer. Jpn J Cancer Res 1994;85:1045-9.
21. Toi M, Inada K, Suzuki H, Tominaga T. Tumor angiogenesis in breast cancer: its importance as a prognostic indicator and the association with vascular endothelial growth factor expression. Breast Cancer Res Treat 1995;36:193-204.
22. Yeo KT, Sioussat TM, Faix JD, Senger DR, Yeo TK. Development of time-resolved immunofluorometric assay of vascular permeability factor. Clin Chem 1992;38:71-5.
23. Yeo KT, Wang HH, Nagy JA, Sioussat TM, Ledbetter SR, Hoogewerf AJ, et al. Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions. Cancer Res 1993;53:2912-8.
24. Kondo S, Asano M, Katsuhiko M, Ohmori I, Suzuki H. Vascular endothelial growth factor/vascular permeability factor is detectable in the sera of tumor-bearing mice and cancer patients. Biochim Biophys Acta 1994;1221:211-4.
25. Fiebich BL, Jäger B, Schöllmann C, Weindel K, Wilting J, Kochs G, et al. Synthesis and assembly of functionally active human vascular endothelial growth factor homodimers in insect cells. Eur J Biochem 1993;211:19-26.
26. Knecht R, Chang JY. Liquid chromatographic determination of amino acids after gas-phase hydrolysis and derivatization with dimethylaminoazobenzene-sulfonyl chloride. Anal Chem 1986;58: 2375-9.
27. Law S-J, Miller T, Piran U, Klukas C, Chang S, Unger J. Novel poly-substituted aryl acridinium esters and their use in immunoassay. J Biolumin Chemilumin 1989;4:88-98.
28. Schlaeppi J-M, Vekemans S, Rink H, Chang JY. Preparation of monoclonal antibodies to hirudin and hirudin peptides. A method for studying the hirudin-thrombin interaction. Eur J Biochem 1990;188:463-70.
29. Sioussat TM, Dvorak HF, Brock TA, Senger DR. Inhibition of vascular permeability factor (vascular endothelial growth factor) with antipeptide antibodies. Arch Biochem Biophys 1993;301: 15-20.
30. Carlsson J, Drevin H, Axén R. Protein thiolation and reversible protein-protein conjugation. N-succinimidyl 3-(2-pyridyldithio)propionate, a new heterobifunctional reagent. Biochem J 1978;173: 723-37.
31. 2-macroglobulin and the binding is inhibited by heparin. J Biol Chem 1993;268:7685-91.
32. 121). Hybridoma 1995;14:475-80.
33. Kim KJ, Li B, Houck K, Winer J, Ferrara N. The vascular endothelial growth factor proteins: identification of biologically relevant regions by neutralizing monoclonal antibodies. Growth Factors 1992;7:53-64.
34. Hanatani M, Tanaka Y, Kondo S, Ohmori I, Suzuki H. Sensitive chemiluminescence enzyme immunoassay for vascular endothelial growth factor/vascular permeability factor in human serum. Biosci Biotech Biochem 1995;59:1958-9.
35. Nagy JA, Masse EM, Herzberg KT, Meyers MS, Yeo KT, Yeo TK, et al. Pathogenesis of ascites tumor growth: vascular permeability factor, vascular hyperpermeability, and ascites fluid accumulation. Cancer Res 1995;55:360-8.